Tissue Engineering of Craniofacial Structure
暂无分享,去创建一个
[1] H. Losken,et al. Rescue of coronal suture fusion using transforming growth factor-beta 3 (Tgf-beta 3) in rabbits with delayed-onset craniosynostosis. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[2] S. Bidic,et al. Rabbit Calvarial Wound Healing by Means of Seeded Caprotite® Scaffolds , 2003, Journal of dental research.
[3] V. Schramm,et al. Resorbable Internal Fixation in Pediatric Cranial Base Surgery , 2002, The Laryngoscope.
[4] H. Schliephake. Bone growth factors in maxillofacial skeletal reconstruction , 2002 .
[5] A. Moursi,et al. Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion. , 2002, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.
[6] J. Wozney. Overview of Bone Morphogenetic Proteins , 2002, Spine.
[7] Cory Berkland,et al. Precise control of PLG microsphere size provides enhanced control of drug release rate. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[8] K. C. Tan,et al. [Individually CAD-CAM technique designed, bioresorbable 3-dimensional polycaprolactone framework for experimental reconstruction of craniofacial defects in the pig]. , 2002, Mund-, Kiefer- und Gesichtschirurgie : MKG.
[9] Scott P Bartlett,et al. Applications of a New Carbonated Calcium Phosphate Bone Cement: Early Experience in Pediatric and Adult Craniofacial Reconstruction , 2002, Plastic and reconstructive surgery.
[10] Mark P. Mooney,et al. Understanding Craniofacial Anomalies , 2002 .
[11] R. Gassner,et al. Effects of fixation type and guided tissue regeneration on maxillary osteotomy healing in rabbits. , 2002, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[12] Y. Lanir,et al. Enhancement of bone defect healing in old rats by TGF-β and IGF-1 , 2002, Experimental Gerontology.
[13] W. Mark Saltzman,et al. Building drug delivery into tissue engineering design , 2002, Nature Reviews Drug Discovery.
[14] Yasuhiro Okazaki,et al. Tissue-Engineered Bone Using Mesenchymal Stem Cells and a Biodegradable Scaffold , 2002, The Journal of craniofacial surgery.
[15] H F Sailer,et al. Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres. , 2002, International journal of oral and maxillofacial surgery.
[16] K. Marra,et al. Surface studies of coated polymer microspheres and protein release from tissue-engineered scaffolds , 2002, Journal of biomaterials science. Polymer edition.
[17] J. de Dios Luna,et al. The contribution of IGF‐I to skeletal integrity in postmenopausal women , 2001, Clinical endocrinology.
[18] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[19] L. Currie,et al. The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. , 2001, Plastic and reconstructive surgery.
[20] J. Goldstein. The use of bioresorbable material in craniofacial surgery. , 2001, Clinics in plastic surgery.
[21] N P Haas,et al. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. , 2001, Bone.
[22] S. Frostick,et al. Neurotrophin‐4 delivered by fibrin glue promotes peripheral nerve regeneration , 2001, Muscle & nerve.
[23] M. Longaker,et al. In vivo modulation of FGF biological activity alters cranial suture fate. , 2001, The American journal of pathology.
[24] J O Hollinger,et al. Controlled Release from Coated Polymer Microparticles Embedded in Tissue-engineered Scaffolds , 2001, Journal of drug targeting.
[25] J. Heersche,et al. Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone. , 2000, Bone.
[26] J. Hubbell,et al. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[27] A. Flyvbjerg,et al. Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions , 2000, Experimental Gerontology.
[28] C. Patrick,et al. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. , 2000, Journal of biomedical materials research.
[29] P. Deluca,et al. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] S. Feng,et al. Nanospheres of biodegradable polymers: a system for clinical administration of an anticancer drug paclitaxel (Taxol). , 2000, Annals of the Academy of Medicine, Singapore.
[31] Y. Ikada,et al. Promoted bone healing at a rabbit skull gap between autologous bone fragment and the surrounding intact bone with biodegradable microspheres containing transforming growth factor-beta1. , 2000, Tissue engineering.
[32] D. Sato,et al. Bone augmentation by onlay implant using recombinant human BMP-2 and collagen on adult rat skull without periosteum. , 2000, Clinical oral implants research.
[33] J L Cleland,et al. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[34] A. Mikos,et al. Effects of transforming growth factor β1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates , 2000 .
[35] A. Mikos,et al. Controlled release of transforming growth factor β1 from biodegradable polymer microparticles , 2000 .
[36] G. Karsenty,et al. The family of bone morphogenetic proteins. , 2000, Kidney international.
[37] Antonios G. Mikos,et al. Growth Factor Delivery for Tissue Engineering , 2000, Pharmaceutical Research.
[38] D. Ornitz,et al. Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures. , 2000, Development.
[39] K. Chihara,et al. Stimulatory Effect of Insulin‐Like Growth Factor Binding Protein‐5 on Mouse Osteoclast Formation and Osteoclastic Bone‐Resorbing Activity , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[40] S Jockenhoevel,et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[41] M. Ito,et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.
[42] S. Giannini,et al. Role of insulin-like growth factor-I in primary osteoporosis: A correlative study , 2000, Journal of endocrinological investigation.
[43] R. Rizzoli,et al. Protein Undernutrition‐Induced Bone Loss Is Associated with Decreased IGF‐I Levels and Estrogen Deficiency , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[44] E. Mathiowitz,et al. Nanosphere based oral insulin delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[45] D J Mooney,et al. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[46] M. Shameem,et al. Extended release peptide delivery systems through the use of PLGA microsphere combinations , 2000, Journal of biomaterials science. Polymer edition.
[47] P. Deluca,et al. Enhancing Initial Release of Peptide from Poly(d,l-lactide-co-glycolide) (PLGA) Microspheres by Addition of a Porosigen and Increasing Drug Load , 2000, Pharmaceutical development and technology.
[48] G. Verbeke,et al. Down‐Regulation of the Serum Stimulatory Components of the Insulin‐like Growth Factor (IGF) System (IGF‐I, IGF‐II, IGF Binding Protein [BP]‐3, and IGFBP‐5) in Age‐Related (Type II) Femoral Neck Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[49] Y. Ikada,et al. Skull bone regeneration in primates in response to basic fibroblast growth factor. , 1999, Journal of neurosurgery.
[50] J A Schrier,et al. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems. , 1999, Pharmaceutical development and technology.
[51] K. Saleh,et al. Osteoinductive growth factors in preclinical fracture and long bone defects models. , 1999, The Orthopedic clinics of North America.
[52] Y. Capan,et al. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[53] T Görner,et al. Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[54] J. Poser,et al. Novel formulation of fibroblast growth factor‐2 in a hyaluronan gel accelerates fracture healing in nonhuman primates , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[55] J O Hollinger,et al. Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats. , 1999, Journal of biomedical materials research.
[56] M. R. Aberturas,et al. Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[57] R. Ziegler,et al. Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: lack of correlation with bone mass. , 1999, Bone.
[58] M. Morishita,et al. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. , 1999, Drug development and industrial pharmacy.
[59] A. Tessler,et al. Neurotrophic agents in fibrin glue mediate adult dorsal root regeneration into spinal cord. , 1999, Neurosurgery.
[60] R. Gref,et al. Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[61] M. Lorenzoni,et al. Guided bone regeneration with barrier membranes--a clinical and radiographic follow-up study after 24 months. , 1999, Clinical oral implants research.
[62] J. Wozney,et al. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. , 1998, Journal of biomedical materials research.
[63] S. W. Kim,et al. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres. , 1998, Journal of biomedical materials research.
[64] S L Woo,et al. The Effects of Platelet-Derived Growth Factor-BB on Healing of the Rabbit Medial Collateral Ligament , 1998, The American journal of sports medicine.
[65] H. Tesluk,et al. Effect of insulin-like growth factor type I on critical size calvarial bone defects in irradiated rats. , 1998, The Journal of craniofacial surgery.
[66] M. Wells,et al. Two lyophilized polymer matrix recombinant human bone morphogenetic protein-2 carriers in rabbit calvarial defects. , 1998, The Journal of craniofacial surgery.
[67] J. Barnes,et al. Effect of Locally Infused IGF‐I on Femoral Gene Expression and Bone Turnover Activity in Old Rats , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[68] T. Wredmark,et al. Insulin-like growth factor I increases bone formation in old or corticosteroid treated rats. , 1997, Acta orthopaedica Scandinavica.
[69] Brooks M. Boyd,et al. The Stability of Recombinant Human Growth Hormone in Poly(lactic-co-glycolic acid) (PLGA) Microspheres , 1997, Pharmaceutical Research.
[70] B. Eppley,et al. Degradation Characteristics of PLLA‐PGA Bone Fixation Devices , 1997, The Journal of craniofacial surgery.
[71] M. Lind,et al. Growth factors: possible new clinical tools. A review. , 1996, Acta orthopaedica Scandinavica.
[72] E. Solheim,et al. Guided tissue regeneration and local delivery of insulinlike growth factor I by bioerodible polyorthoester membranes in rat calvarial defects. , 1996, The International journal of oral & maxillofacial implants.
[73] C. Kiritsy,et al. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. , 1996, Journal of periodontal research.
[74] P. Boyne. Animal studies of application of rhBMP-2 in maxillofacial reconstruction. , 1996, Bone.
[75] R Langer,et al. Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes , 1996, Biotechnology and bioengineering.
[76] J. Wozney,et al. Poly(α-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration , 1996 .
[77] J. Hollinger,et al. A Bone Regeneration Study: Transforming Growth Factor‐β1 and Its Delivery , 1996 .
[78] M. Buckley,et al. The Effects of Guided Tissue Regeneration and Fixation Technique on Osseous Wound Healing in Rabbit Zygomatic Arch Osteotomies , 1996, The Journal of craniofacial surgery.
[79] R. Marcus,et al. Effects of recombinant insulin‐like growth factor‐I and growth hormone on bone turnover in elderly women , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[80] J. Hollinger,et al. Delivery of Demineralized Bone Powder by Fibrin Sealant , 1995, Plastic and reconstructive surgery.
[81] S. Mohan,et al. An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone , 1995, Calcified Tissue International.
[82] P. Speight,et al. Effect of poly DL-lactide--co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. , 1994, Biomaterials.
[83] J. Massagué,et al. The TGF-β family and its composite receptors , 1994 .
[84] C. R. Howlett,et al. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. , 1994, Bone.
[85] J. Wozney,et al. Transforming Growth Factor-β Gene Family Members and Bone* , 1994 .
[86] J. Baker,et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.
[87] A. Losken,et al. Osseous guided tissue regeneration using a collagen barrier membrane. , 1993, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[88] M. Urist,et al. Osteoinductive Activity of Composites of Bone Morphogenetic Protein and Pure Titanium , 1993, Clinical orthopaedics and related research.
[89] T. Tanaka,et al. Morphological study of recombinant human transforming growth factor beta 1-induced intramembranous ossification in neonatal rat parietal bone. , 1993, Bone.
[90] Mark E. Bolander,et al. Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[91] E. Amento,et al. Rapid publication TGF‐β1 induces bone closure of skull defects , 1991 .
[92] M S Reddy,et al. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. , 1991, Journal of periodontology.
[93] H. Antoniades,et al. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. , 1989, Journal of clinical periodontology.
[94] P. Aspenberg,et al. Fibroblast growth factor stimulates bone formation. Bone induction studied in rats. , 1989, Acta orthopaedica Scandinavica.
[95] M. Urist,et al. Induction of callus formation by implants of bone morphogenetic protein and associated bone matrix noncollagenous proteins. , 1988, Clinical orthopaedics and related research.
[96] J. Glowacki,et al. APPLICATION OF THE BIOLOGICAL PRINCIPLE OF INDUCED OSTEOGENESIS FOR CRANIOFACIAL DEFECTS , 1981, The Lancet.
[97] M. Urist,et al. Bone: Formation by Autoinduction , 1965, Science.
[98] Gary R. Grotendorst,et al. Platelet-derived growth factor enhances demineralized bone matrix-induced cartilage and bone formation , 2007, Calcified Tissue International.
[99] J. Mcvie,et al. Polymer-coated albumin microspheres as carriers for intravascular tumour targeting of cisplatin , 2004, Cancer Chemotherapy and Pharmacology.
[100] P. Marie,et al. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. , 2002, Histology and histopathology.
[101] D. Rohner,et al. Individuell mit CAD-CAM-Technik hergestellte, bioresorbierbare dreidimensionale Polycaprolaktongerüste zur experimentellen Rekonstruktion von kraniofazialen Defekten beim Schwein , 2002, Mund-, Kiefer- und Gesichtschirurgie.
[102] J. Hubbell,et al. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. , 1999, Bioconjugate chemistry.
[103] A. Pandit,et al. Stimulation of angiogenesis by FGF-1 delivered through a modified fibrin scaffold. , 1998, Growth factors.
[104] G. Daculsi,et al. Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: an in vitro study. , 1998, Bone.
[105] E. Solheim. Growth factors in bone , 1998, International Orthopaedics.
[106] J. Glowacki,et al. Sex steroids, the insulin-like growth factor regulatory system, and aging: implications for the management of older postmenopausal women. , 1998, The journal of nutrition, health & aging.
[107] K. Leong,et al. Poly(α-hydroxy acids). Carriers for bone morphogenetic proteins , 1996 .
[108] P. Deluca,et al. Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres. , 1995, Journal of pharmaceutical and biomedical analysis.
[109] H. Oxlund,et al. Local injection of TGF-β increases the strength of tibial fractures in the rat , 1994 .
[110] O. Illi,et al. Biodegradable implant materials in fracture fixation. , 1992, Clinical materials.
[111] F. Greco,et al. Fibrin-antibiotic mixtures: an in vitro study assessing the possibility of using a biologic carrier for local drug delivery. , 1991, Journal of biomedical materials research.
[112] E. Edelman,et al. Controlled Release of Fibroblast Growth Factor: Activity in Cell Culture , 1991 .
[113] S. Mohan,et al. Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. , 1990, Metabolism: clinical and experimental.
[114] M. Vitiello,et al. Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone. , 1985, Journal of gerontology.
[115] G. Stanek,et al. In vitro properties of mixtures of fibrin seal and antibiotics. , 1983, Biomaterials.